Mar 3
|
Qiagen N.V. (QGEN): Among the Cash-Rich Mid Cap Stocks to Buy Now
|
Mar 3
|
QIAGEN takes legal action to defend QuantiFERON intellectual property and protect innovations in latent tuberculosis testing
|
Feb 23
|
2 Recent Stock Splits You've Never Heard of That Certain Wall Street Analysts Think Could Soar 39% and 62%
|
Feb 14
|
Institutional owners may take dramatic actions as Qiagen N.V.'s (NYSE:QGEN) recent 5.6% drop adds to one-year losses
|
Feb 13
|
QIAGEN Strengthens Global Bioinformatics Leadership With New Data Center in Australia/Asia-Pacific Region
|
Dec 30
|
Why Is Qiagen N.V. (QGEN) Among the Top CRISPR Stocks to Invest In?
|
Dec 30
|
New Product Offerings Support QIAGEN's Shares Amid Currency Woes
|
Dec 30
|
Here's Why Qiagen (QGEN) is a Strong Momentum Stock
|
Sep 27
|
Those who invested in Qiagen (NYSE:QGEN) five years ago are up 41%
|
Sep 27
|
Qiagen secures EU IVDR certification for QIAstat-Dx systems and panels
|
Sep 27
|
QGEN Stock to Gain From New IVDR Win for QIAstat-Dx Systems and Panels
|
Sep 26
|
QIAGEN receives European IVDR certification for QIAstat-Dx syndromic testing instruments and assays
|
Sep 26
|
QIAGEN Stock Likely to Gain From PreAnalytiX's Newly Launched PAXgene
|
Sep 26
|
PreAnalytiX introduces urine liquid biopsy solution
|
Sep 25
|
PreAnalytiX, a QIAGEN and BD joint venture, launches novel solution for liquid biopsy from urine samples
|
Sep 24
|
QGEN Stock Might Rise on Partnership With Bode for GEDmatch PRO
|
Sep 23
|
QIAGEN and Bode Technology partner to advance use of GEDmatch PRO forensic genetic genealogy database
|
Sep 23
|
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
|
Sep 5
|
QIAGEN Stock Likely to Gain on Collaboration for APOE Genotyping
|
Sep 5
|
Qiagen and Lilly team up for Alzheimer’s genotype test
|